Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Arch Biopartners Inc
V.ARCH
Alternate Symbol(s):
ACHFF
Technology
Scientific & Technical Instruments
Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is...
LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:ARCH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Aug 15, 2021 5:15pm
HUGE UPSIDE - 83% Efficacy in animal studies... Human data?
when mice
...more
(9)
•••
Riverfolk
X
View Profile
View Bullboard History
Post by
Riverfolk
on Aug 15, 2021 5:06pm
Great Read !!
Thank you champ for posting, please find below the article posted along with the cell publication on Metablok. The COVID-19 Cytokine Storm; What we know so far Dipeptidase-1 Is an Adhesion Receptor
...more
(2)
•••
2019champs
X
View Profile
View Bullboard History
Post by
2019champs
on Aug 15, 2021 10:19am
Older article i found interesting
https://www.frontiersin.org/articles/10.3389/fimmu.2020.01446/full "Complete blood picture of COVID-19 patients usually shows lymphopenia with or without total leukopenia. A lymphocyte count
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Aug 14, 2021 2:39pm
Break Out Stocks
https://www.baystreet.ca/articles/breakoutstocks.aspx?id=3026
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Aug 13, 2021 9:39pm
Happy Friday the 13th
All time high and all time high close
(2)
•••
2019champs
X
View Profile
View Bullboard History
Comment by
2019champs
on Aug 13, 2021 6:53pm
RE:RE:Company that's doing everything right
You're right golden arm, but if you have a good company, with a legitimate drug with good efficacy, there's only so much the sloppy algos can do. Heck, i wish the tsx guys had a huge short
...more
(54)
•••
GoldenArm
X
View Profile
View Bullboard History
Comment by
GoldenArm
on Aug 13, 2021 1:31pm
RE:Company that's doing everything right
Yes but we know the Nasdaq is a market filled with snakes. 80K shares and big move on price. Something good is coming.
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Aug 13, 2021 12:45pm
New all time high
Another $4-5 imho
(2)
•••
2019champs
X
View Profile
View Bullboard History
Post by
2019champs
on Aug 13, 2021 11:38am
Company that's doing everything right
You don't really see that alot in penny stocks. 90% is junk. These guys have a game changing drug. Wait til this thing gets on the nasdaq. This could be big folks.
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Aug 13, 2021 10:57am
Diamond Hands
If you think these shareholders are going to sell for 30% gains after being loyal for years, you're incorrect! Make them work for it !
(180)
•••
stocksarefun
X
View Profile
View Bullboard History
Comment by
stocksarefun
on Aug 13, 2021 10:13am
RE:Price Reaches a New 52 Week High
And just getting started.
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Aug 13, 2021 10:13am
Price Reaches a New 52 Week High
Price Reaches a New 52 Week High Alert Sent 2021-08-13 10:06:16 AM ET Arch Biopartners Inc TSXV:ARCH Last Price 1.71 Today's Change (%) +0.01 (0.59%) Bid / Lots 1.69 / 1 Ask / Lots&
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Post by
TheBearInTheWoods
on Aug 13, 2021 9:56am
1.70 Venture - 1.35 OTC
The seller portion of the question has been answered, note it's up the buyers.
(2)
•••
2019champs
X
View Profile
View Bullboard History
Post by
2019champs
on Aug 12, 2021 10:22pm
Kidney inflammation a potential side effect from the vaccine
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drugs-regulator-looking-new-possible-side-effects-mrna-vaccines-2021-08-11/
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
One Property, One Focus on Advancing this Gold Project in Ontario